Skip to main content
. 2010 Apr 30;192(13):3268–3278. doi: 10.1128/JB.00118-10

FIG. 8.

FIG. 8.

Inhibition of ctRNA/mIncα complex formation by specific oligonucleotides. (a) Electrophoretic mobility shift assay (EMSA) of 32P-labeled ctRNA and its target (mIncα) in the presence of oligonucleotides complementary to the ctRNA left arm (ODN5′), complementary to the ctRNA right arm (ODN3′), or both, as described in Materials and Methods. (b) Graphic representation of the relative complex formation obtained from three independent EMSA assays.